Isoflurane is a widely used inhalational anesthetic agent, known by several trade names including Forane and Terrell. It belongs to a class of drugs called volatile anesthetics, which are administered to patients undergoing surgical procedures to induce and maintain general anesthesia. Isoflurane was first introduced in the late 1970s and has since become a staple in operating rooms around the world due to its favorable pharmacokinetic properties and safety profile.
The primary targets of isoflurane are the central nervous system (CNS) and the cardiovascular system. It works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. This makes it incredibly useful in a variety of surgical settings, from minor outpatient procedures to major operations requiring deep anesthesia.
Research institutions across the globe continue to study isoflurane to understand its full range of effects, optimize its use, and investigate potential new applications. For example, researchers are exploring the neuroprotective effects of isoflurane in cases of
traumatic brain injury and
stroke. Despite its long history of use, ongoing studies aim to refine its application to enhance patient safety and outcomes.
Isoflurane is typically indicated for the induction and maintenance of general anesthesia. It is particularly valued for its rapid onset and recovery times, as well as its ability to provide stable cardiovascular conditions during surgery. Recent research has focused on its use in pediatric anesthesia and its potential benefits in elderly patients, who may be more sensitive to the effects of anesthetics.
Isoflurane works primarily by interacting with various ion channels in the brain and spinal cord to produce its anesthetic effects. One of its key targets is the gamma-aminobutyric acid (GABA) receptor, which is a major inhibitory neurotransmitter in the CNS. Isoflurane enhances the activity of GABA at these receptors, leading to increased chloride ion influx into neurons. This hyperpolarizes the neurons, making them less likely to fire and thus leading to the sedation and anesthetic effects.
Additionally, isoflurane inhibits the activity of excitatory neurotransmitters like glutamate by blocking
N-methyl-D-aspartate (NMDA) receptors. This suppression of excitatory neurotransmission further contributes to its anesthetic properties. Isoflurane also affects other ion channels, including
potassium and
sodium channels, which play roles in neuronal excitability and signal propagation.
The combination of these effects on the CNS results in a profound depression of neuronal activity, rendering the patient unconscious and insensate. Moreover, isoflurane has muscle relaxant properties, which are beneficial during surgical procedures that require immobility.
Isoflurane is administered via inhalation, using a calibrated vaporizer to ensure accurate dosing. The vaporizer is connected to an anesthetic machine, which delivers a mixture of isoflurane and oxygen (and sometimes
nitrous oxide) to the patient through a mask or an endotracheal tube.
The onset of action of isoflurane is relatively rapid, with patients typically losing consciousness within a few minutes of inhalation. The depth of anesthesia can be easily adjusted by modifying the concentration of isoflurane delivered. Maintenance of anesthesia is achieved by continuing to administer the drug at the desired concentration throughout the procedure.
The duration of the anesthetic effect depends on the length of administration. Once the procedure is complete, the administration of isoflurane is discontinued, and the patient is allowed to breathe 100% oxygen to expedite the elimination of the drug from the body. Isoflurane is eliminated primarily through exhalation, with minimal metabolism by the liver.
Patients generally regain consciousness within minutes after the cessation of isoflurane, although complete recovery of cognitive and motor functions can take longer, depending on the duration and depth of anesthesia.
While isoflurane is generally well-tolerated, it can cause several side effects. Common side effects include
hypotension (low blood pressure),
respiratory depression, and
nausea or
vomiting during the recovery period. Some patients may experience
shivering or chills as they wake up from anesthesia.
Serious but rare side effects include
malignant hyperthermia, a life-threatening condition characterized by a rapid increase in body temperature and severe
muscle rigidity. This condition is a medical emergency and requires immediate treatment with
dantrolene and supportive measures.
Isoflurane is contraindicated in patients with known hypersensitivity to the drug or other halogenated anesthetics. It should also be used with caution in patients with a history of malignant hyperthermia or those with severe cardiovascular or
respiratory diseases, as it can exacerbate these conditions.
Chronic exposure to isoflurane, particularly in occupational settings, can have deleterious effects on health. Anesthesiologists and other healthcare personnel should use adequate ventilation and scavenging systems to minimize exposure.
Several drugs can interact with isoflurane, affecting its efficacy and safety. For instance, concurrent use of other CNS depressants, such as benzodiazepines, opioids, or barbiturates, can potentiate the sedative effects of isoflurane, requiring careful dose adjustments.
Beta-blockers and
calcium channel blockers, commonly used to manage
hypertension and
cardiac conditions, can enhance the hypotensive effects of isoflurane. Conversely, stimulants like amphetamines can antagonize the anesthetic effects, necessitating higher doses of isoflurane to achieve the desired level of anesthesia.
The use of neuromuscular blocking agents, such as
succinylcholine, can be affected by isoflurane, which may potentiate their muscle relaxant effects. This interaction can prolong neuromuscular blockade and complicate the recovery of muscle function post-surgery.
In conclusion, isoflurane remains a cornerstone in anesthetic practice due to its efficacy, rapid onset, and safety profile. Understanding its mechanisms of action, proper administration techniques, potential side effects, and drug interactions is crucial for optimizing patient care and outcomes. As research continues to expand our knowledge of isoflurane, its role in anesthesia and potentially other medical applications will likely evolve, further cementing its importance in modern medicine.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


